🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 1 randomized, open-label, multicenter, parallel-group study designed ...
Status
Completed
Location
Yeungnam University Hospital
Start Date
2016-09-29
Trial ID
NCT02883452
The aim of this clinical trial is to assess the efficacy and safety of Infl...
Status
Completed
Location
Services Institute of Medical Sciences
Start Date
2022-10-01
Trial ID
NCT05663268
Treatments Being Tested
An observational, prospective cohort study to evaluate the safety and effic...
Status
Terminated
Location
Multiple Locations
Start Date
2014-12-08
Trial ID
NCT02326155
This phase I/II trial studies the side effects of infliximab and vedolizuma...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-09
Trial ID
NCT04407247
Treatments Being Tested
This is a Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safe...
Status
Completed
Location
Hanyang University Medical Center
Start Date
2016-09-12
Trial ID
NCT03147248
The primary objective is to assess if discontinuation of anti- tumor necros...
Status
Completed
Location
Helse Møre og Romsdal, Ålesund Sjukehus
Start Date
2017-06-09
Trial ID
NCT03011268
Treatments Being Tested
Study type : A 30 months, multicentre, open-label strategic randomized cont...
Status
Unknown
Location
GETAID
Start Date
2021-12-21
Trial ID
NCT05072782
Treatments Being Tested
This study compares two administration methods of CT-P13. Half of participa...
Status
Completed
Location
PPD Development, LP
Start Date
2018-02-21
Trial ID
NCT03446976
Treatments Being Tested
A subcutaneous formulation of infliximab CT-P13 (Remsima, Celltrion) has be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07120152
Treatments Being Tested
This is a post-marketing observational study of patients with Inflammatory ...
Status
Completed
Location
UZ Leuven Campus Gasthuisberg
Start Date
2015-04-22
Trial ID
NCT02539368